Biotech

All Articles

A nearer consider Ferocious Biotech's Fierce 15

.Within this full week's incident of "The Best Line," our team are actually diving in to Strong Biot...

Lilly encounters stage 2 failing of tau-targeting med

.The confetti is still flying from Eli Lilly's event celebrating the commendation of Alzheimer's dis...

Biogen CMO Maha Radhakrishnan participates in Sofinnova-- Chutes &amp Ladders

.Welcome to recently's Chutes &amp Ladders, our roundup of significant leadership hirings, firings a...

Lykos are going to inquire FDA to reconsider its own choice adhering to being rejected of MDMA therapy for trauma

.Following a poor presenting for Lykos Therapeutics' MDMA prospect for post-traumatic stress disorde...

AN 2 halves census, ceases phase 3 test after information dissatisfy

.AN2 Rehabs is reassessing its business in action to uninspired midphase information, pledging to la...

Merck pays $700M for bispecific, spying autoimmune position as well as odds to test Amgen in cancer

.Merck &amp Co. is actually spending $700 thousand in advance to challenge Amgen in a blood cancer c...

Gilead spends J&ampJ $320M to go out licensing offer for seladelpar

.With Gilead Sciences on the verge of an FDA decision for its liver ailment medicine seladelpar, the...

' All palms on deck' at Lilly as peers target being overweight market

.CEO David Ricks can easily view the business putting together camping tents at basecamp responsible...

Entero laying off personnel, leaving workplace as well as stopping R&ampD

.Bed mattress Liquidators has transformed Entero Therapies white colored as a slab. The creditor got...

Exelixis goes down ADC after deciding it is actually no suit for Tivdak

.Exelixis is surrendering on its own cells aspect (TF)- targeting antibody-drug conjugate after endi...